POPULARITY
Categories
Thanks Donna for selecting today's drug name! She left a voicemail asking for pronunciation help via the contact page on my website https://www.thepharmacistsvoice.com. In this episode, I divide Myrbetriq and mirabegron into syllables, tell you which syllables to emphasize, and share my sources. Written pronunciations are helpful! They are below and in the show notes on www.thepharmacistsvoice.com/podcast (select episode 326). Myrbetriq = meer-BEH-trick Meer, like a mirror BEH, like Belize (a country in Central America) Trick, like “Trick or Treat” Emphasize the middle syllable - BEH Sources: (1) Prescribing Information for Myrbetriq (patient information section) on the FDA's website, (2) ispot.tv, and (3) Myrbetriq's website https://www.myrbetriq.com/ Mirabegron = MIR-a-BEG-ron MIR, like a mirror A, which is a short “A” sound (uh) BEG, like a dog begs for a treat Ron, like Ron Weasley (Harry Potter's friend) Emphasize MIR and BEG. BEG gets the most emphasis. Sources: MedlinePlus and the USP Dictionary Online If you know someone who would like to learn how to say Myrbetriq or mirabegron, please share this episode with them. Subscribe for all future episodes. This podcast is on all major podcast players and YouTube. Popular links are below. ⬇️ Apple Podcasts https://apple.co/42yqXOG Spotify https://spoti.fi/3qAk3uY Amazon/Audible https://adbl.co/43tM45P YouTube https://bit.ly/43Rnrjt Recommend a drug name for this series via email: kim@thepharmacistsvoice.com or leave a voicemail message for me through the contact tab on my website https://www.thepharmacistsvoice.com. ⭐️ Sign up for The Pharmacist's Voice ® monthly email newsletter! https://bit.ly/3AHJIaF Host Background: Kim Newlove has been an Ohio pharmacist since 2001 (BS Pharm, Chem Minor). Her experience includes hospital, retail, compounding, and behavioral health. She is also an author, voice actor (medical narrator and audiobook narrator), podcast host, and consultant (audio production and podcasting). Links from this episode Prescribing information for Myrbetriq on FDA's website. (Accessed 4-17-25) Myrbetriq commercial (ispot.tv) https://www.ispot.tv/ad/wcLD/myrbetriq-enough-is-enough Myrbetriq's website https://www.myrbetriq.com/ Mirabegron on MedlinePlus (accessed 4-17-25) https://medlineplus.gov/druginfo/meds/a612038.html USP Dictionary Online (Subscription-based resource) USP Dictionary's pronunciation guide (Free resource, American Medical Association's website) The Pharmacist's Voice Podcast Episode 324, Pronunciation Series Episode 52 (liraglutide) The Pharmacist's Voice Podcast Episode 322, Pronunciation Series Episode 51 (ketamine) The Pharmacist's Voice Podcast Episode 320, Pronunciation Series Episode 50 (Jantoven) The Pharmacist's Voice Podcast Episode 318, Pronunciation Series Episode 49 (ipratropium) The Pharmacist's Voice Podcast Episode 316, Pronunciation Series Episode 48 (hyoscyamine) The Pharmacist's Voice Podcast Episode 313, Pronunciation Series Episode 47 (guaifenesin) The Pharmacist's Voice Podcast Episode 311, Pronunciation Series Episode 46 (fluticasone) The Pharmacist's Voice Podcast Episode 309, Pronunciation Series Episode 45 (empagliflozin) The Pharmacist's Voice Podcast Episode 307, Pronunciation Series Episode 44 (dapagliflozin) The Pharmacist's Voice Podcast Episode 304, Pronunciation Series Episode 43 (cetirizine) The Pharmacist's Voice Podcast Episode 302, Pronunciation Series Episode 42 (buspirone) The Pharmacist's Voice Podcast Episode 301, Pronunciation Series Episode 41 (azithromycin) The Pharmacist's Voice Podcast Episode 298, Pronunciation Series Episode 40 (umeclidinium) The Pharmacist's Voice Podcast Episode 296, Pronunciation Series Episode 39 (Januvia) The Pharmacist's Voice Podcast Episode 294, Pronunciation Series Episode 38 (Yasmin) The Pharmacist's Voice Podcast Episode 292, Pronunciation Series Episode 37 (Xanax, alprazolam) The Pharmacist's Voice Podcast Episode 290, Pronunciation Series Episode 36 (quetiapine) The Pharmacist's Voice Podcast Episode 287, pronunciation series ep 35 (bupropion) The Pharmacist's Voice Podcast Episode 285, pronunciation series ep 34 (fentanyl) The Pharmacist's Voice Podcast Ep 281, Pronunciation Series Ep 33 levothyroxine (Synthroid) The Pharmacist's Voice ® Podcast Ep 278, Pronunciation Series Ep 32 ondansetron (Zofran) The Pharmacist's Voice ® Podcast Episode 276, pronunciation series episode 31 (tocilizumab-aazg) The Pharmacist's Voice ® Podcast Episode 274, pronunciation series episode 30 (citalopram and escitalopram) The Pharmacist's Voice ® Podcast Episode 272, pronunciation series episode 29 (losartan) The Pharmacist's Voice Podcast Episode 269, pronunciation series episode 28 (tirzepatide) The Pharmacist's Voice Podcast Episode 267, pronunciation series episode 27 (atorvastatin) The Pharmacist's Voice Podcast Episode 265, pronunciation series episode 26 (omeprazole) The Pharmacist's Voice Podcast Episode 263, pronunciation series episode 25 (PDE-5 inhibitors) The Pharmacist's Voice Podcast Episode 259, pronunciation series episode 24 (ketorolac) The Pharmacist's Voice ® Podcast episode 254, pronunciation series episode 23 (Paxlovid) The Pharmacist's Voice ® Podcast episode 250, pronunciation series episode 22 (metformin/Glucophage) The Pharmacist's Voice Podcast ® episode 245, pronunciation series episode 21 (naltrexone/Vivitrol) The Pharmacist's Voice ® Podcast episode 240, pronunciation series episode 20 (levalbuterol) The Pharmacist's Voice ® Podcast episode 236, pronunciation series episode 19 (phentermine) The Pharmacist's Voice ® Podcast episode 228, pronunciation series episode 18 (ezetimibe) The Pharmacist's Voice ® Podcast episode 219, pronunciation series episode 17 (semaglutide) The Pharmacist's Voice ® Podcast episode 215, pronunciation series episode 16 (mifepristone and misoprostol) The Pharmacist's Voice ® Podcast episode 211, pronunciation series episode 15 (Humira®) The Pharmacist's Voice ® Podcast episode 202, pronunciation series episode 14 (SMZ-TMP) The Pharmacist's Voice ® Podcast episode 198, pronunciation series episode 13 (carisoprodol) The Pharmacist's Voice ® Podcast episode 194, pronunciation series episode 12 (tianeptine) The Pharmacist's Voice ® Podcast episode 188, pronunciation series episode 11 (insulin icodec) The Pharmacist's Voice ® Podcast episode 184, pronunciation series episode 10 (phenytoin and isotretinoin) The Pharmacist's Voice ® Podcast episode 180, pronunciation series episode 9 Apretude® (cabotegravir) The Pharmacist's Voice ® Podcast episode 177, pronunciation series episode 8 (metoprolol) The Pharmacist's Voice ® Podcast episode 164, pronunciation series episode 7 (levetiracetam) The Pharmacist's Voice ® Podcast episode 159, pronunciation series episode 6 (talimogene laherparepvec or T-VEC) The Pharmacist's Voice ® Podcast episode 155, pronunciation series episode 5 Trulicity® (dulaglutide) The Pharmacist's Voice ® Podcast episode 148, pronunciation series episode 4 Besponsa® (inotuzumab ozogamicin) The Pharmacist's Voice ® Podcast episode 142, pronunciation series episode 3 Zolmitriptan and Zokinvy The Pharmacist's Voice ® Podcast episode 138, pronunciation series episode 2 Molnupiravir and Taltz The Pharmacist's Voice ® Podcast episode 134, pronunciation series episode 1 Eszopiclone and Qulipta Kim's websites and social media links: ✅ Guest Application Form (The Pharmacist's Voice Podcast) https://bit.ly/41iGogX ✅ Monthly email newsletter sign-up link https://bit.ly/3AHJIaF ✅ LinkedIn Newsletter link https://bit.ly/40VmV5B ✅ Business website https://www.thepharmacistsvoice.com ✅ Get my FREE eBook and audiobook about podcasting ✅ The Pharmacist's Voice ® Podcast https://www.thepharmacistsvoice.com/podcast ✅ Drug pronunciation course https://www.kimnewlove.com ✅ Podcasting course https://www.kimnewlove.com/podcasting ✅ LinkedIn https://www.linkedin.com/in/kimnewlove ✅ Facebook https://www.facebook.com/kim.newlove.96 ✅ Twitter https://twitter.com/KimNewloveVO ✅ Instagram https://www.instagram.com/kimnewlovevo/ ✅ YouTube https://www.youtube.com/channel/UCA3UyhNBi9CCqIMP8t1wRZQ ✅ ACX (Audiobook Narrator Profile) https://www.acx.com/narrator?p=A10FSORRTANJ4Z ✅ Start a podcast with the same coach who helped me get started (Dave Jackson from The School of Podcasting)! **Affiliate Link - NEW 9-8-23** Thank you for listening to episode 326 of The Pharmacist's Voice ® Podcast. If you know someone who would like this episode, please share it with them!
On the Mad in America podcast this week, Brooke Siem, author of May Cause Side Effects, talks with Teralyn Sell and Jenn Schmitz about their journey from working in the prison system to challenging conventional psychiatric narratives in their therapy practice and podcast, The Gaslit Truth. Dr. Teralyn Sell is a distinguished expert in Psychology and Brain Health, holding a PhD in Psychology and an MS in Counseling Psychology. She bridges the gap between traditional mental health care and integrative brain health solutions with formal training in holistic nutrition and biology. She is the author of Your Best Brain and the co-host of the internationally acclaimed podcast, The Gaslit Truth, where she challenges conventional narratives around mental health and medication. Dr. Teralyn is dedicated to promoting safe medication practices, responsible tapering and a paradigm shift in mental health care, one that prioritizes brain health over symptom management. Jenn Schmitz is redefining the field of psychology with a unique blend of expertise and lived experience. Holding a Master of Science in Clinical Psychology and having spent over a decade as a traditional therapist, Jenn took a bold step beyond the conventional boundaries of Western education and mental health treatment. Her personal struggle, marked by the challenging process of tapering off psychiatric medication, revealed insights that reshaped her entire approach to mental health. As a holistic, de-prescribing consultant, Jenn integrates psychological and brain health expertise with physical wellness, mindfulness and nutrition to safely guide the brain through the intricate process of medication tapering. Jenn hosts The Gaslit Truth podcast along with Dr. Teralyn and is a writer for the international wellness publication, Live, Love and Eat magazine. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2025. Produced by James Moore https://www.jmaudio.org
Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after organ transplants. Optimal doses can vary by patient ethnicity and are key to successful transplantation.Speaker 3: (00:32) Could you provide us a with little bit about your background and yourself? Speaker 3: (03:45) Will you please provide a brief overview of Mayo test 3A5Q? Speaker 3: (06:56) Which patients should have this testing, and when should it be performed? Speaker 3: (08:15) What alternative or complementary tests should be considered? Speaker 3: (09:25)How are the results used in patient care? Speaker 3: (10:38)Will you help the audience understand the significance of monitoring tacrolimus levels for transplant rejection? Speaker 3: (12:53)What alleles are included in this test?
SummaryIn this powerful and personal conversation, MASS Cultural Council Executive Director, Michael Bobbitt explores the life-saving role of the arts, how creative work is inherently political, and the deep importance of joy, community, and innovation in building a better future. Drawing on his personal story, leadership journey, and groundbreaking initiatives, Bobbitt challenges arts organizations to think boldly and cross-sectorally in their work for social change.
Before I introduce you to today's guest, I want to take a quick moment to share a recap from our recent 2-day Intensive that we hosted for Predictive clients and guests on March 19th and 20th. If you're not familiar with our Intensives, three times a year — March, July, and November — we bring our Predictive clients together on Zoom for what we call the “2-day Intensive.” It's where we pull back the curtain on Predictive's best strategies and tactics, breaking everything down in full transparency so our clients can take the key insights and install them into their agencies. This past March, we focused on one critical goal — helping agencies sell more of what they do. Drew McLellan, CEO of Agency Management Institute, kicked things off on Day 1 with a deep dive into how to build and nurture a thriving community. On Day 2, Hannah Roth — our Director of Strategy and resident Mad Scientist here at Predictive — absolutely crushed it. She walked us through key components of the sales process — including a technique she calls Align and Prescribe. That's exactly why I invited Hannah to join me on today's episode. We break down Align and Prescribe step by step, so you can see how it works — and most importantly, how you can put it into action inside your agency. If you take what Hannah shares today and apply it, you and your team will be Aligning and Prescribing like pros and closing more sales in a way that feels natural, confident, and right-fit. What you will learn in this episode: How to set the stage with confidence and own the conversation Recapping your prospective client's concerns turns potential pitfalls into trust-building moments Hannah's high impact questions that will shorten the sales cycle How to leverage storytelling instead of relying solely on facts The subtle transitions from help me understand calls to aligning on solutions that resonate deeply with right-fit prospects How you can get Hannah's new eBook on Align and Prescribe Resources: Website: www.predictiveroi.com Visit our newly expanded Resource Library Join us in our free How to Fill Your Sales Pipeline Facebook Group Hannah's LinkedIn: www.linkedin.com/in/hannah-roth-387a6b223/ Order your free paperback or Kindle copy of our Book: Sell with Authority
In this JCO Article Insights episode, Lauren Shih summaries "Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons–Accredited Cancer Programs" by Jessica L. Burris, et al published November 19, 2024. Come back for the next episode where JCO After Hours host, Dr. Davide Soldato interviews the author of the JCO article discussed, Dr. Jessica Burris. TRANSCRIPT Lauren Shih: Hello and welcome to JCO Article Insights. I'm your host Lauren Shih, and today we will be discussing the article, “Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment in American College of Surgeons–Accredited Cancer Programs” by Dr. Jessica Burris and colleagues published in the March issue of JCO. This study reports the finding of the Just ASK Initiative, an effort aimed at improving universal smoking assessment in cancer programs nationwide. We know that smoking after a cancer diagnosis is associated with numerous negative outcomes including worse survival, increased treatment related complications, poorer quality of life and higher healthcare costs. Patients who smoke are also at increased risk for cancer recurrence and second primary malignancies. Despite these risks, data show that a significant number of patients with newly diagnosed cancer still smoke and around 15% of cancer survivors continue smoking. Recognizing this discrepancy, national oncology organizations strongly recommend routine smoking assessment and cessation support as part of standard cancer care. However, despite these guidelines, smoking assessment and cessation assistance remain inconsistent across oncology practices. Surveys show that most National Cancer Institute designated cancer centers have insufficient resources to effectively support smoking cessation efforts. To address this gap, several large scale initiatives have been launched, including efforts by the National Cancer Institute, the Canadian Partnership Against Cancer, and the American College of Surgeons. The largest of these initiatives, through the American College of Surgeons, is the subject of our report today. In 2022, the American College of Surgeons introduced the Just ASK Quality Improvement Program with the goal of increasing routine smoking assessment. As member institutions, accredited programs are required to complete at least one quality improvement program annually. And in 2022, 40% of programs chose to participate in Just ASK. The primary goal of this quality improvement program was to ask at least 90% of newly diagnosed cancer patients about their smoking status. Offering smoking cessation support was encouraged, but not a mandatory component or primary endpoint for the initiative. To implement Just ASK, participating programs used a well-established Plan-Do-Study-Act methodology which is a structured, iterative approach for improving healthcare processes. Programs used local quality improvement teams and resources for implementation and had access to online training, educational webinars, and technical resources to help integrate smoking assessment into routine care. Programs completed three surveys: a baseline survey reflecting smoking assessment practices in the year before Just ASK; a midpoint survey after six months of participation; and a final survey after one year in the program. The surveys assess program characteristics, barriers to smoking assessment, readiness to change, and the frequency of smoking related clinical practices such as asking about smoking, documenting smoking status, and advising smoking cessation. Programs reported on implementation strategies they adopted to improve smoking assessment. Finally, programs reported the number of newly diagnosed cancer patients they saw, how many were asked about their smoking status and how many were identified as current smokers during each reporting period. Results from 762 participating cancer center programs were analyzed. The programs represented a diverse mix of practice sites with over 50% identified as community based. Retention in the program was high, with nearly 90% of programs completing the final survey. Most programs reported moderate organizational readiness at baseline along with an average of 4.6 implementation barriers to conducting routine smoking assessment. Barriers included factors such as lack of time, competing clinical priorities, and lack of designated tobacco treatment specialists. At baseline, the ask rate was 87.8% and this increased to 91.9% at the final survey, meeting the previously identified goal for the initiative. Throughout the initiative, programs reported increases over time in assessing smoking status, in advising patients who smoked and quit, and in documenting these assessments and recommendations in the medical record. Importantly, the smoking rate among patients asked ranged from 18.5% to 19.8% across the three surveys, demonstrating a high rate of current smoking among newly diagnosed cancer patients. The most common implementation strategies adopted by programs to promote change included gaining leadership support, improving documentation on the electronic health record, and training staff and providers. There were no major differences in implementation strategies based on program type. Organizational readiness was positively associated with better smoking assessment practices, and implementation barriers had a negative impact, although not always statistically significant. The number of implementation strategies used by programs showed a positive, significant association with smoking assessment practices at the final survey. Exploratory analyses did not suggest that program type or patient volume had a consistent relationship with the outcomes. Although the primary goal of Just ASK was smoking assessment and not cessation assistance or intervention, programs did report on cessation related practices. For example, programs reported providing education or self-help materials increased from 26% to 48%, referrals to tobacco treatment specialists increased from 25% to 35%, and referrals to quit lines increased from 27% to 45%. Prescribing or recommending FDA approved cessation medications increased from 17% to 21%. In conclusion, Just ASK is the largest nationwide initiative to standardize and improve smoking assessment in cancer care. It successfully improves smoking assessment across a diverse range of cancer practices, ensuring that hundreds of thousands of newly diagnosed cancer patients were asked about their smoking status. As nearly 20% of the cohort reported smoking, this represents a critical first step in helping patients access smoking cessation resources. Participating programs demonstrated small but sustained practice changes in smoking assessment, meeting the a priori determined goal of a 90% ask rate. However, as a quality improvement initiative, Just ASK was not designed as a clinical trial, so conclusions regarding the efficacy of the program as an intervention are limited. Selection bias may have also played a role in the findings as program participation was voluntary. Additionally, the initiative lasted just one year and while the initial improvements were steady during that time, the long term impacts of Just ASK on smoking assessment remain uncertain. Looking ahead, the American College of Surgeons recently completed the Beyond ASK initiative. This initiative is designed to go a step further and focuses on improving smoking cessation assistance and we await the results. The Just ASK initiative demonstrates the routine smoking assessment is feasible to complete as routine cancer care. This assessment is essential as identifying patients that smoke is the first and critical step towards offering smoking cessation support, which in turn can improve health outcomes and reduce cancer treatment costs. While Just ASK was a success in increasing assessment, the challenge now is ensuring that smoking cessation support is readily available for all patients who need it. Thank you for listening to JCO Article Insights. Please give us a rating or review and subscribe so you never miss a JCO episode. You can find all ASCO shows at asco.org/podcasts. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement.
In this episode expert guest Dr. CM Schade elaborates on the Texas Medical Board's revamped CME requirements for opioid prescriptions, which now focus only on direct patient care physicians. He offers insights into how the new rules bring flexibility while placing an emphasis on meticulous documentation. With decades of experience in legislative advocacy, Dr. Schade shares valuable tips on navigating these changes and encourages utilizing TMA's educational resources. Access the ondemand webinar - Prescribing and Monitoring of Controlled Substances Access current TMB rules
Erin Fuse Brown is a professor of health services, policy, and practice at the Brown University School of Public Health and a member of the Journal's Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.C. Fuse Brown, O.J. Wouters, and A. Mehrotra. Partnerships between Pharmaceutical and Telehealth Companies — Increasing Access or Driving Inappropriate Prescribing? N Engl J Med 2025;392:1148-1151.
In this CME podcast, Dr. Andrew Cutler and Dr. Roger McIntyre discuss the use of potentially unsafe drug combinations in patients with treatment-resistant psychiatric conditions. They review situations where complex medication regimens may be necessary and how clinicians may proceed in these instances. By addressing these topics, the podcast offers guidance on balancing the potential benefits of combination therapies with the risks associated with polypharmacy in psychiatric care. Target Audience: This activity has been developed for the healthcare team or individual prescriber specializing in mental health. All other healthcare team members interested in psychopharmacology are welcome for advanced study. Learning Objectives: After completing this educational activity, you should be better able to: Identify common potentially unsafe drug combinations that may be considered in treatment-resistant cases Evaluate the risks and benefits of prescribing potentially unsafe drug combinations for treatment-resistant patients, considering factors such as efficacy, adverse effects, and patient-specific characteristics Develop strategies to monitor and manage patients prescribed potentially unsafe drug combinations Accreditation: In support of improving patient care, this activity has been planned and implemented by HMP Education and Neuroscience Education Institute (NEI). HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Activity Overview: This activity is available with synchronized audio and is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications. A post-test score of 70% or higher is required to receive CME/CE credit. Estimated Time to Complete: 1 hour. Released: March 26, 2025* Expiration: March 25, 2028 *NEI maintains a record of participation for six (6) years. CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD25-01 Credit Designations: The following are being offered for this activity: Physician: ACCME AMA PRA Category 1 Credits™ HMP Education designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Nurse: ANCC contact hours This continuing nursing education activity awards 1.00 contact hour. Provider approved by the California Board of Registered Nursing, Provider #18006 for 1.00 contact hour. Nurse Practitioner: ACCME AMA PRA Category 1 Credit™ American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME. The content in this activity pertaining to pharmacology is worth 1.00 continuing education hour of pharmacotherapeutics. Pharmacy: ACPE application-based contact hours This internet enduring, knowledge-based activity has been approved for a maximum of 1.00 contact hour (.10 CEU). The official record of credit will be in the CPE Monitor system. Following ACPE Policy, NEI and HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity and are unable to report your claimed credit after this 60-day period. Ensure your profile includes your DOB and NABP ID. Physician Associate/Assistant: AAPA Category 1 CME credits HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with the AAPA CME Criteria. This internet enduring activity is designated for 1.00 AAPA Category 1 credit. Approval is valid until March 25, 2028. PAs should only claim credit commensurate with the extent of their participation. Psychology: APA CE credits Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. This activity awards 1.00 CE Credit. Social Work: ASWB-ACE CE credits As a Jointly Accredited Organization, HMP Education is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this internet enduring course receive 1.00 general continuing education credit. Non-Physician Member of the Healthcare Team: Certificate of Participation HMP Education awards hours of participation (consistent with the designated number of AMA PRA Category 1 Credit™) to a participant who successfully completes this educational activity. Interprofessional Continuing Education: IPCE credit for learning and change This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change. Peer Review: The content was peer-reviewed by an MD, MPH specializing in forensics, psychosis, schizophrenia, mood disorders, anxiety, and cognitive disorders — to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. NEI and HMP Education take responsibility for the content, quality, and scientific integrity of this CME/CE activity. Disclosures: All individuals in a position to influence or control content are required to disclose any relevant financial relationships. Any relevant financial relationships were mitigated prior to the activity being planned, developed, or presented. Faculty Author / Presenter Andrew J. Cutler, MD Clinical Associate Professor, Department of Psychiatry and Behavioral Sciences, Norton College of Medicine, State University of New York Upstate Medical University, Syracuse, New York Chief Medical Officer, Neuroscience Education Institute, Malvern, Pennsylvania Consultant/Advisor: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, Biogen, BioXcel, Boehringer Ingelheim, Brii Biosciences, Cerevel, Corium, Delpor, Evolution Research, Idorsia, Intra-Cellular, Ironshore, Janssen, Jazz, Karuna, Lundbeck, LivaNova, Luye, MapLight Therapeutics, Neumora, Neurocrine, NeuroSigma, Noven, Otsuka, Relmada, Reviva, Sage Therapeutics, Sumitomo (Sunovion), Supernus, Takeda, Teva, Tris Pharma, VistaGen Therapeutics Speakers Bureau: AbbVie, Acadia, Alfasigma, Alkermes, Axsome, BioXcel, Corium, Idorsia, Intra-Cellular, Ironshore, Janssen, Lundbeck, Neurocrine, Noven, Otsuka, Sumitomot (Sunovion), Supernus, Takeda, Teva, Tris Pharma, Vanda Data Safety Monitoring Board (DSMB): COMPASS Pathways, Freedom Biosciences Faculty Author / Presenter Roger S. McIntyre, MD, FRCPC Professor, Departments of Psychiatry and of Pharmacology, University of Toronto, Toronto, Ontario, Canada CEO, Braxia Scientific Corp, Toronto, ON, Canada Grant/Research: Canadian Institutes of Health Research, China National Natural Research Foundation, Global Alliance for Chronic Diseases, Milken Institute Consultant/Advisor: Alkermes, Atai Life Sciences, Axsome, Bausch Health, Biogen, Eisai, Intra-Cellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neumora Therapeutics, Neurocrine, NewBridge Pharmaceuticals, Novo Nordisk, Otsuka, Pfizer, Purdue, Sage, Sanofi, Sunovion, Takeda, Viatris The remaining Planning Committee members, Content Editors, Peer Reviewer, NEI and HMP planners/staff have no financial relationships to disclose. NEI and HMP Education planners and staff include Gabriela Alarcón, PhD, Ali Holladay, Andrea Zimmerman, EdD, CHCP, Brielle Calleo, and Steven S. Simring, MD, MPH. Disclosure of Off-Label Use: This educational activity may include discussion of unlabeled and/or investigational uses of agents that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses. Cultural Linguistic Competency and Implicit Bias: A variety of resources addressing cultural and linguistic competencies and strategies for understanding and reducing implicit bias can be found in this handout—download me. Accessibility Statement For questions regarding this educational activity, or to cancel your account, please email customerservice@neiglobal.com. Support: This activity is supported solely by the provider, NEI.
This week's guest, pharmacist Dr. Kathy Campbell, challenges conventional wisdom about health, obesity, and medication. Dr. Campbell shares her journey from childhood obesity to becoming a "wellness pharmacist" dedicated to helping patients avoid medications through proper nutrition and lifestyle adjustments. She reveals why being "nutrient empty" is the real culprit behind many modern health issues and offers practical insights into creating true wellness.Guest InformationDr. Kathy Campbell is a pharmacist with over 33 years of experience who owns her independent pharmacy in Tulsa, Oklahoma. She's the author of "Obesity: The Modern Famine" and advocates for a prevention-focused approach to healthcare. She speaks nationally and internationally on pharmacist-led lifestyle medicine and is working to create a network of wellness pharmacies across the country.Website: drkathydoes.comBook: "Obesity: The Modern Famine"Products: Dr. Kathy Nourish salts and spicesShe shared her recipe for Spicy Chicken Soup--one of the favorites of her cooking class attendeesEpisode Highlights[00:00:00] Introduction to Dr. Kathy Campbell and her unique approach as a "wellness pharmacist"[00:01:00] Dr. Campbell's journey into pharmacy and her 33-year practice in one community[00:04:00] How Dr. Campbell expanded beyond pharmaceuticals to include botanicals, nutrients, and food[00:05:00] Dr. Campbell's personal experience with childhood obesity and her family history[00:06:00] Discussion of "Obesity: The Modern Famine" and the concept of nutrient deficiency[00:08:00] How obesity is a symptom of underlying metabolic chaos, not just overeating[00:10:00] The impact of stress chemistry on weight gain and health[00:13:00] Dr. Campbell's experience growing up in a family where obesity was normal[00:14:00] How Dr. Campbell helps patients optimize or reduce medications[00:16:00] The role of pharmacists as chemistry experts in healthcare[00:17:00] How patients end up "on empty" and the limitations of the current healthcare system[00:20:00] Dr. Campbell's approach to determining individual nutrient needs[00:22:00] The challenges of advocating for wellness in a medication-focused profession[00:24:00] Alarming statistics about chronic disease in children today (54% under 18)[00:26:00] Dr. Campbell's vision for a network of wellness pharmacies[00:27:00] The changing role of patients in curating their own healthcare team[00:29:00] Discussion of the business of healthcare versus actual care[00:31:00] How food quality impacts health and the importance of eating "non-poisoned" food[00:33:00] Dr. Campbell's services, including medication consultations and coaching[00:36:00] Dr. Campbell's work with other pharmacists and international speakingKey Quotes"My goal as a pharmacist is not to fill prescriptions. It's to have people not need medications." - Dr. Campbell"We have been groomed to think that health is in the pill bottle and at the doctor's office. The reality is health is before that." - Dr. Campbell"I wanted to blow the conception that obesity was a problem of too much food....
Benzodiazepines: Risks, Origins, and Prescribing
Can Art, Nature, and Community Replace Pills? What if doctors prescribed a painting class instead of or alongside pills? Journalist Julia Hotz, author of The Connection Cure, joins M3 Jeff Goddard, and MD/PhD student Riley Behan-Bush to discuss social prescribing, a growing healthcare movement that treats patients with art, nature, movement, and community rather than just medication. We look at the barriers to making this idea work in the U.S., from insurance hurdles to physician overwork to healthcare's obsession with quick fixes. But the UK's social prescribing model reduced ER visits by up to 50%, and it acknowledges loneliness might be as dangerous as smoking 15 cigarettes a day. Can medical students lead the charge toward healthcare that actually reduces physicians' moral injury? More about our guest: https://www.hotzthoughts.com/ https://www.socialprescribing.co/ https://www.simonandschuster.com/books/The-Connection-Cure/Julia-Hotz/9781668030332 We Want to Hear From You: YOUR VOICE MATTERS! We welcome your feedback, listener questions, and shower thoughts. Do you agree or disagree with something we said today? Did you hear something really helpful? Can we answer a question for you? Are we delivering a podcast you want to keep listening to? Let us know at https://theshortcoat.com/tellus and we'll put your message in a future episode. Or email theshortcoats@gmail.com. The Short Coat Podcast is FeedSpot's
Modern Wisdom Key Takeaways The insurance companies and big pharma complex monetize chronic diseaseThey benefit if more Americans are chronically ill because it means more prescriptions and therefore more kickbacks and rebates Approximately 30% of the revenue generated from opioid abuse in America went to the big five insurance companies The insurance companies are incentivized to put you on drugs!About 60% of United Healthcare's annual revenue – $361 billion in 2024 – comes from prescription drugs via an entity called a pharmacy benefit manager The average American is on 4+ prescription drugs SSRIs are one of the most worrisome drugs of the day: A metaanalysis of over 75 studies revealed that 85% of the efficacy of an SSRI was related to placebo On a 52-point depression scale, SSRIs differentiate from placebo by 1-2 points The healthcare system is not broken; it is rigged, and the American taxpayer is the one footing the bill “Prescribing a GLP-1 without talking about diet, lifestyle, and nutrition is like brushing your teeth while eating Oreos.” – Brigham Buhler Behind age and smoking, the third biggest cause of chronic disease is metabolic diseaseTo fix the healthcare system, fixing metabolic health should be our primary focusWe have built an entire healthcare industry of siloed experts, but the body is one organism; we should adopt a more holistic approach to treatment Using AI to build a better system: We will use algorithmic-based medicine to take a proactive and predictive approach to medicine, which will reduce the onset of chronic disease immediately upon recognition Faster iteration phases between detection and intervention will improve our health Read the full notes @ podcastnotes.orgBrigham Buhler is a healthcare entrepreneur, founder and CEO of Ways2Well, and co-founder of ReviveRx Pharmacy. American healthcare stands apart from any other system in the world. While some argue it has the potential to be the best, for many, it feels like the worst. Sky-high costs, an overreliance on prescriptions, and systemic inefficiencies suggest something is deeply broken. Why is this the case, and what can be done to fix it? Expect to learn what the number one reason for bankruptcy in America is, what the average state of health is for the average American and how it compares to the rest of the world, why so many American's are on Pharmaceutical drugs, what drugs Americans are taking that are causing the most damage, what is happening with the Food industry's corporate capture of food, how much of an impact RFK can really have on changing the pharmaceutical and food system, the simple changes that can improve American healthcare and much more… Sponsors: See discounts for all the products I use and recommend: https://chriswillx.com/deals Get a Free Sample Pack of all LMNT Flavours with your first purchase at https://drinklmnt.com/modernwisdom Get $350 off the Pod 4 Ultra at https://eightsleep.com/modernwisdom (use code MODERNWISDOM) Get a 20% discount on Nomatic's amazing luggage at https://nomatic.com/modernwisdom Get the best bloodwork analysis in America at https://functionhealth.com/modernwisdom Extra Stuff: Get my free reading list of 100 books to read before you die: https://chriswillx.com/books Try my productivity energy drink Neutonic: https://neutonic.com/modernwisdom Episodes You Might Enjoy: #577 - David Goggins - This Is How To Master Your Life: https://tinyurl.com/43hv6y59 #712 - Dr Jordan Peterson - How To Destroy Your Negative Beliefs: https://tinyurl.com/2rtz7avf #700 - Dr Andrew Huberman - The Secret Tools To Hack Your Brain: https://tinyurl.com/3ccn5vkp - Get In Touch: Instagram: https://www.instagram.com/chriswillx Twitter: https://www.twitter.com/chriswillx YouTube: https://www.youtube.com/modernwisdompodcast Email: https://chriswillx.com/contact - Learn more about your ad choices. Visit megaphone.fm/adchoices
Chris Appleton is the founder and CEO of Art Pharmacy, a pioneering initiative using social prescribing to integrate the arts into healthcare and improve mental well-being. A leader in arts and social impact, his work has been featured in The New York Times, CNN, and NPR. With a background in nonprofit leadership Chris is redefining healing one creative prescription at a time. This episode: What if a doctor's prescription didn't lead you to a pharmacy, but to a painting class, a dance performance, or a music workshop? For centuries, artists have played a vital role in well-being, and cultures around the world have embraced the arts as a source of health, community, and renewal. Now, social prescribing is reshaping healthcare by integrating the arts, not just as enrichment but as a science-backed tool for improving both mental and physical health. Decades of research show that engaging in the arts can reduce stress, lower blood pressure, strengthen the immune system, and improve cognitive function. As the founder and CEO of Art Pharmacy, Chris Appleton is proving that creative engagement is more than a feel-good activity. It is a legitimate, measurable intervention that enhances health outcomes. By working with healthcare providers and insurers, he is building a system where doctors can prescribe the arts just like they would medication or therapy. Grant and Chris also explore how programs like Prebys Foundation's Healing Through Arts and Nature initiative are improving community health through greater access to arts, culture, and nature. Grant shares how his own experience stepping onto the dance floor at a recent grantee event led to an unexpected moment of joy, connection, and uplifted spirits that reinforced the power of the arts in fostering well-being.
Did you know that one in four Australians could be silently battling hypertension without even realizing it? In this compelling episode, we dive deep with experienced naturopath Tracee Blythe into the often-overlooked relationship between blood pressure, diabetes, and the transformative potential of integrative medicine approaches.With nearly two decades of clinical expertise, Tracee unveils the concerning statistics behind Australia's hypertension crisis while offering fellow naturopaths a fresh perspective on co-prescribing strategies that bridge conventional and natural medicine. You'll discover how commonly prescribed anti-hypertensive medications can deplete essential nutrients in your patients—and how targeted natural interventions can effectively address these imbalances.This episode delivers practice-changing insights on:Evidence-based natural interventions, including garlic and omega-3 supplements that rival pharmaceutical outcomesHow to confidently integrate complementary approaches alongside conventional treatmentsPatient-centred strategies for home monitoring that dramatically improve clinical outcomesThe critical nutritional considerations often missed in conventional treatment plansPractical frameworks for co-prescribing that enhance your clinical effectivenessWhether you're supporting patients with established hypertension or focusing on preventative care, this conversation offers actionable protocols that expand your clinical toolkit. The scientific evidence is clear: lifestyle and nutritional interventions can produce results comparable to medications—knowledge that empowers your practice and transforms patient outcomes.Don't miss Tracee's upcoming educational webinar designed specifically for naturopathic practitioners looking to master the art of co-prescribing in hypertension management.Register for Tracee's webinar here: Webinar: Integrative Co-Prescribing Anti-Hypertensive MedicationsConnect with Tracee: Tracee Blythe ConsultingSubscribe to the podcast and leave a review to help us spread the word about this critical health conversation!Get in touch! Shownotes and references are available on the Designs for Health websiteRegister as a Designs for Health Practitioner and discover quality practitioner- only supplements at www.designsforhealth.com.au Follow us on Socials Instagram: Designsforhealthaus Facebook: Designsforhealthaus DISCLAIMER: The Information provided in the Wellness by Designs podcast is for educational purposes only; the information presented is not intended to be used as medical advice; please seek the advice of a qualified healthcare professional if what you have heard here today raises questions or concerns relating to your health
Explore the role of antidepressants in older adults, weighing risks and benefits, deprescribing, and alternative strategies. Listen to expert insights in this podcast. Read the Blog: https://medcast.com.au/blog/prescribing-with-care-antidepressants-and-mental-health-in-older-adults Log this CPD with the Medcast CPD Tracker: https://medcast.com.au/account/management/cpd?createActivity=139706&utm_source=soundcloud
Our Top 3 VideosFear & greedGold "crush"?Prescribing profits Hosted on Acast. See acast.com/privacy for more information.
Prescribing GLP-1 Medications: Be Aware of Legal Limitations Ericka Adler and fellow Roetzel attorney Christina Kuta discuss the potential pitfalls and best practices in dispensing GLP-1 medications. Christina shares her insights on the surge in demand, the concerning shortcuts being taken due to shortages, and the critical questions surrounding who is prescribing and dispensing these medications. They explore the state and federal regulations governing distribution, including the nuances of online services, interstate pharmacy relationships, and the crucial requirement of proper licensing for those dispensing to patients. Ericka and Christina also address the rise of compounded GLP-1 drugs, the potential risks associated with non-FDA approved alternatives, and the importance of verifying the integrity and quality of medications. Finally, the podcast covers the need for thorough staff training and maintaining accurate patient records as it relates to all medications being dispensed. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen
In this podcast, Kristin and Julianne follow on from last month's Part 1 of Prescribing Medicinal Mushrooms by further discussing how they individually prescribe medicinal mushrooms based on the mushroom's clinical affinities and therapeutic actions. Kristin and Julianne differentiate the use of specific medicinal mushrooms in both cardiometabolic and nervous system/mood patient presentation, as well as provide the key clinical pictures for each of OptimalRx's eleven medicinal mushroom extracts. To learn more about our medicinal mushrooms and to obtain your free copy of the medicinal mushroom educational resource pack, please log into your OptimalRx account online. -- Available to registered practitioners only.Send us a textwww.optimalrx.com.au
Hochul is not ruling out removing Adams over allegations the mayor made a "quid pro quo" deal with the DOJ...A Texas judge is ordering a NY doctor to pay $100,000 for prescribing abortion pills to a woman near Dallas full 395 Fri, 14 Feb 2025 10:57:30 +0000 NrDf6OkKHnNfsqSiNezGJEg0PkDV1vf0 news 1010 WINS ALL LOCAL news Hochul is not ruling out removing Adams over allegations the mayor made a "quid pro quo" deal with the DOJ...A Texas judge is ordering a NY doctor to pay $100,000 for prescribing abortion pills to a woman near Dallas The podcast is hyper-focused on local news, issues and events in the New York City area. This podcast's purpose is to give New Yorkers New York news about their neighborhoods and shine a light on the issues happening in their backyard. 2024 © 2021 Audacy, Inc.
On this episode of #HealthLawHotSpot, Ericka Adler and fellow Roetzel attorney Christina Kuta discuss the potential pitfalls and best practices in dispensing GLP-1 medications. Christina shares her insights on the surge in demand, the concerning shortcuts being taken due to shortages, and the critical questions surrounding who is prescribing and dispensing these medications. They explore the state and federal regulations governing distribution, including the nuances of online services, interstate pharmacy relationships, and the crucial requirement of proper licensing for those dispensing to patients. Ericka and Christina also address the rise of compounded GLP-1 drugs, the potential risks associated with non-FDA approved alternatives, and the importance of verifying the integrity and quality of medications. Finally, the podcast covers the need for thorough staff training and maintaining accurate patient records as it relates to all medications being dispensed. If you're a provider considering offering GLP-1 drugs or even if you are a patient concerned about the source of your medications, this episode is a must-listen.
Reese, Jasmin and Janet discuss the Lunar New Year, a NY doctor being indicted in Louisiana for prescribing abortion pills, language related to diversity, equity, inclusion, and accessibility being removed from government websites, the Kenyan government cracking down on seed sharing among farmers, and traditional stilt walking making a comeback in China among young people.
In this episode, we explore the vital aspects of prescribing lamotrigine, from its mechanisms to titration schedules. Did you know that birth control pills can cut lamotrigine levels in half within just one week? Understanding these interactions is crucial for safe and effective treatment. Faculty: Scott Beach, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.5 CME: Lamotrigine: From Current Indications to Cardiac Side Effects Understanding Lamotrigine Mechanisms and Titration Schedule
AP's Lisa Dwyer reports on the indictment of a doctor who prescribed an abortion pill.
"Homeopathy Primer" is not just a book; it's a treasure trove of knowledge for every home! In this episode, Abby Beale reveals how this guide can simplify your homeopathic journey. Explore the features of Homeopathy Primer, including its user-friendly layout, the innovative red, orange, and blue dosing method, and the inclusion of tissue salts. Abby emphasizes the importance of knowing when to seek medical help and how this book empowers parents to take charge of their family's health. Episode Highlights: 02:37 - How a 90-Minute Consultation Changed My Son's Health 04:39 - The Magic of Homeopathy for Children 06:13 - Overview of Homeopathy Primer 13:08 - When to Seek Medical Help 19:41 - A color-coded system for dosing homeopathic remedies based on urgency 22:44 - The Importance of Acute Prescribing Skills 24:52 - Inclusion of Tissue Salts in the Book 28:15 - Pricing and Value of Homeopathy Primer 30:38 - Where to Purchase the Book 32:08 - Affiliate Program and Community Support About my Guest: Abby Beale is a nationally certified classical homeopath who sees clients in her office in Northampton, MA as well as over the internet via Skype and Zoom. She became aware of homeopathy when her son was 9 months old and had repeated ear infections. One visit to a homeopath and one remedy later, her son didn't have another ear infection. She began studying in earnest in 2003. She believes that homeopathy is the most awesome healing modality on the planet. Abby is a consummate educator and has recently published a new book called Homeopathy Primer: Getting Started with Homeopathy with the help of 35 other experienced practitioners, students and home users. She truly loves to educate consumers about the power of homeopathy. You can buy the book here and save $20 with the code hangout20: https://homeopathyprimer.com/products/homeopathy-primer-release-edition-july-2024 If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode. Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/ Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom
A patient's mindset not only influences their experience and satisfaction level, but research indicates it can also impact their physical, mental, and emotional health. So how can members of the healthcare team influence the patient's mindset in a meaningful way? Mindset researcher Kari Leibowitz, PhD, has studied this topic extensively and is helping healthcare professionals embrace the healing potential of prescribing perspective. Dr. Leibowitz, a Stanford-trained PhD, was the lead author of a newly published paper on mindset training. She discusses that research, as well as practical ways healthcare professionals can prescribe mindset. About the Expert Kari Leibowitz is a health psychologist with a PhD in psychology from Stanford University, where she conducted research at the Stanford Mind & Body Lab. She is a U.S.-Norway Fulbright Scholar and a frequently invited writer and speaker on the power of mindset. Leibowitz has written about "wintertime mindset" for The New York Times and The Washington Post, and her work has been covered by The Guardian, CNN, National Geographic, Forbes, The Telegraph, BBC, and New Scientist. Her first book, How to Winter: Harness Your Mindset to Thrive on Cold, Dark, or Difficult Days, is available now. More information at karileibowitz.com.
How can businesses successfully navigate the relentless pace of change without alienating employees? Why do so many change initiatives fail, and what role does communication play in driving successful transformations?In this episode of the Value Creators Podcast, Hunter Hastings speaks with Nellie Wartoft, founder and CEO of TigerHall, about a revolutionary approach to organizational change—change activation. Nellie explains how businesses can move beyond outdated, top-down "change management" processes to foster bottom-up, action-driven change that engages employees and aligns with company culture.Key insights include:Why employees resist change when they lack a voice and feel excluded from the process.How TigerHall uses data, personalization, and modern content formats (videos, podcasts, live streams) to activate change effectively.The importance of two-way feedback loops, real-time insights, and ongoing execution to drive agile, impactful transformations.Why culture is defined by who you hire and how behaviors are rewarded and recognized.For leaders seeking to address change fatigue, retain top talent, and create agile organizations, this episode provides a roadmap to activate meaningful and lasting transformation.Resources: Discover how TigerHall helps businesses navigate change in a human, engaging, and data-driven way.The Executive Council For Leading ChangeConnect with Nellie Wartoft on LinkedIn➡️ Learn What They Didn't Teach You In Business School: The Value Creators Online Business CourseConnect with Hunter Hastings on LinkedInThe Value Creators on SubstackShow Notes:0:00 | Intro2:02 | Change is the Only Constant: The Concept of Change Management in Corporate America and Its Challenges4:57 | Increasing Frequency of Changes Employees Face and its Impact on Engagement 5:35 | Subjective Value8:39 | Change Activation and its Importance Over Traditional Change Management. 13:04 | Change with the Organization14:42 | Overview of TigerHall's Platform and its Features for Driving Change Activation. 18:12 | TigelHall's Content Creation Process 20:42 | Dynamic Audience Group: Targeting messages 22:09 | Value Creators Online Course23:22 | AI-driven targeted messaging24:16 | Self Selection 25:26 | Success Story and the Role of Culture in Change Management and its Challenges29:19 | Giving Individuals a Voice31:37 | Culture 34:49 | The Flow Concept: Future of Change Management and the Need for Adaptable Professionals37:52 | Training People with Special Skills and Experience40:40 | Wrap-Up
This week, Scott & Sean discuss: Biblical Perspective on Southern California FiresExploring the theological implications of natural disasters, addressing questions about God's sovereignty and goodness amidst tragedy.Rising Global Anti-SemitismReport showing an alarming increase in anti-Semitic sentiments worldwide, especially among younger generations, and highlights the role of social media in spreading these views.Pharmacists Prescribing Abortion PillsExamines the new policy in Washington State and its broader implications, including ethical, medical, and biblical perspectives.Listener QuestionsOn human rights, biblical definitions of flourishing, and the church's responsibility to address poverty and inequality.==========Think Biblically: Conversations on Faith and Culture is a podcast from Talbot School of Theology at Biola University, which offers degrees both online and on campus in Southern California. Find all episodes of Think Biblically at: https://www.biola.edu/think-biblically. Watch video episodes at: https://bit.ly/think-biblically-video. To submit comments, ask questions, or make suggestions on issues you'd like us to cover or guests you'd like us to have on the podcast, email us at thinkbiblically@biola.edu.
The Functional Nurse Podcast - Nursing in Functional Medicine
On this episode of the Functional Nurse Podcast, Brigitte Sager, DNP discusses the important distinctions between education, recommendations, and prescribing within the nursing scope of practice. She emphasizes the role of nurses in educating patients, the nuances of making recommendations, and the importance of empowering patients to make informed decisions about their health. The conversation also touches on the use of online dispensaries for quality supplements and the significance of clear communication in nursing practice. Link to Brigitte's Full Script Dispensary: https://us.fullscript.com/welcome/manifestwellbeing/store-start
NO ADVICE OF ANY KIND. My guest today is Dr. Gautam Gulati, known to most as Dr. G. He is a visionary health artist who designs luxury spaces that embody health and longevity. As the founder of The Well Home, he envisions and transforms homes into wellness sanctuaries that promote health and prevent disease. With over 25 years of experience, Dr. G has significantly impacted global brands by challenging the status quo and inspiring innovation. Dubbed "the Rick Rubin of audio storytelling," he captivates audiences with his award-winning audio docuseries called SUPERHUMANS. When off duty, Dr. G could easily be mistaken for Bollywood royalty. He captivates audiences worldwide as a renowned keynote speaker and cherishes outdoor life with his family in Great Falls, VA. Please join me in welcoming Dr. G for an in-depth conversation that explores his unconventional journey as an award-winning doctor and designer, and why he now calls himself an 'asset manager'. Summary In this conversation, Dr. Gautam Gulati, a visionary health artist and founder of The Well Home, discusses his journey from a family of medical professionals to his current role as an asset manager of health. He emphasizes the importance of holistic health, the power of storytelling in healing, and the significance of purpose in achieving longevity. Dr. Gulati shares insights on how our biographies shape our biology and the need for a more integrated approach to health that includes mental, emotional, and financial well-being. He also reflects on the transformative power of public speaking and the connections formed through shared stories. In this conversation, Dr. Gautam Gulati and Bogumil Baranowski explore the significance of in-person interactions, the role of innovation in driving change, and the obstacles that hinder progress. They discuss the importance of designing living spaces that promote health and wellness, particularly in the context of aging and chronic conditions. The conversation culminates in a discussion about defining success holistically, emphasizing the freedom to live life on one's own terms. Company: https://www.thewellho.me/ Speaking (health): https://www.thewellho.me/speaking Speaking (innovation): https://www.drgautamgulati.com/ Audio Docuseries: www.superhumans.health LinkedIn: https://www.linkedin.com/in/gautamgulati/ Instagram: https://www.instagram.com/drgautamgulati/ Podcast Program – Disclosure Statement Blue Infinitas Capital, LLC is a registered investment adviser and the opinions expressed by the Firm's employees and podcast guests on this show are their own and do not reflect the opinions of Blue Infinitas Capital, LLC. All statements and opinions expressed are based upon information considered reliable although it should not be relied upon as such. Any statements or opinions are subject to change without notice. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Information expressed does not take into account your specific situation or objectives, and is not intended as recommendations appropriate for any individual. Listeners are encouraged to seek advice from a qualified tax, legal, or investment adviser to determine whether any information presented may be suitable for their specific situation. Past performance is not indicative of future performance.
Unicist case-taking, and most contemporary homeopathic approaches, including the method taught at MICH, lead to a deep and thorough exploration of a patient's inner landscape, including un-integrated life experiences. In this audio presentation, Adam Fiore, homeopath, naturopath and holistic pratitioner explains how to work with vulnerability, trauma, wounding within unicist prescribing, and how important it is to know how to support such clients to ‘feel', and what language leads to the vital sensation. He also covers important topics such as Spiritual bypassing, maturing and using homeopathy for spiritual growth, and highlights the particular usefulness of the Bird remedies and the Caryophyllidae plants in this context. I am Adam Fiore, DHom HOM ND DHP, a clinical supervisor and Materia Medica teacher at the Montreal Institute of Classical Homeopathy. I love running our clinical focus sessions, alive with hands on and experiential apprenticeship. We share the expertise that enables students to address the dynamic root of disease by finding the ideal homeopathic similimum and bring homeopathy to its full potential as an energy medicine. Ours is a fully accredited, self-paced program that also includes supporting our patients' healing process through individualized diet, naturopathy and coaching. Contact us at info@michmontreal.com Visit the MICH Website for all the information about our program: https://www.michmontreal.com/ Enrollment is now open for a full 2 hour webinar: Energetic Pattern of Birds in Homeopathy on the Bird kingdom in homeopathy by MICH teacher and clinical supervisor, Adam Fiore, DHom HOM ND DHP. In this advanced and in depth exploration of the Bird Kingdom, the MICH Method will be illustrated through in depth clinical case examples with long term follow ups. Sign up to our newsletter to get access to free training webinars in homeopathy. Blog: https://www.michmontreal.com/blog/ and free homeopathy webinars Instagram: https://www.instagram.com/michmontreal/ Facebook: https://www.facebook.com/michmontreal/ Linked in: https://www.linkedin.com/school/montreal-institute-of-classical-homeopathy/ Free Guidebook Download : https://www.michmontreal.com/learn/guidebook-download/
Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from December 21-27, 2024.
Is This Normal?: A Podcast of the Michigan State University College of Nursing
SEND US FAN MAILIn this episode, we talk with Dr. Veronica Bernacchi, a health disparity scientist and nurse researcher, about how social determinants of health (SDOH) impact cancer outcomes. Bernacchi explains SDOH—factors like income, access to healthcare, and living conditions—and how they contribute to cancer disparities, especially in rural and underserved communities.We explore how telehealth can improve access to care, its challenges, and how nurses can play a key role in bridging gaps by building trust and supporting patients. Bernacchi also highlights the importance of understanding community strengths and using culturally sensitive approaches to promote health equity.This conversation illuminates the systemic barriers to cancer care and the steps we can take to create more equitable outcomes for all patients.To find your breaking news and latest updates within the College of Nursing, please refer to our website at nursing.msu.edu. You can also find us on all social media platforms @MICHSTNursingIf you have a question for our hosts or a prospective guest, please message us at: MCOM.nursing@msu.edu
Web: www.JonesHealthLaw.com Phone: (305)877-5054 Instagram: @JonesHealthLaw Facebook: @JonesHealthLaw YouTube: @JonesHealthLaw Controlled substances are drugs or chemicals whose manufacture, possession, or use is regulated by the government due to its potential for abuse, addiction, or harm. They have potential for abuse or dependence and are regulated under the Controlled Substances Act (CSA) in the United States. These substances are classified into five schedules based on their potential for abuse and their medical use. --- Support this podcast: https://podcasters.spotify.com/pod/show/joneshealthlaw/support
In this episode Dhineli Perera speaks to John Turnidge, who leads the national surveillance program for Antimicrobial Use and Resistance in Australia. They discuss the significant impact of the pandemic on reducing antibiotic use in the community, and how this benefit can be sustained and improved on. Read the full article by John and his co-authors, Carolyn Hullick and Kim Stewart, in Australian Prescriber.
Join the dialogue - text your questions, insights, and feedback to The Dignity Lab podcast.In this episode of the Dignity Lab, Jennifer explores the complex relationship between Thanksgiving and dignity, particularly in relation to Indigenous peoples. She discusses the true meaning of gratitude, differentiating between superficial forms of gratitude and a deeper, transformative practice that honors both ourselves and others. Through this exploration, she emphasizes the importance of recognizing genuine kindness and the full spectrum of human experience.TakeawaysThe modern Thanksgiving celebration often overlooks the dignity of Indigenous peoples.Gratitude can be understood as both a tool and a virtue.Comparative gratitude can lead to a harmful mindset that limits gratitude to only times in which others suffer.Social or performative gratitude does not reflect true feelings or experiences.Prescribing gratitude to those in pain can violate their dignity.True gratitude emerges from acceptance and recognition of kindness and acknowledges both challenges and gifts in life.Recognizing goodness in others honors their dignity and our shared humanity.Exploring what it means to live and lead with dignity at work, in our families, in our communities, and in the world. What is dignity? How can we honor the dignity of others? And how can we repair and reclaim our dignity after harm? Tune in to hear stories about violations of dignity and ways in which we heal, forgive, and make choices about how we show up in a chaotic and fractured world. Hosted by physician and coach Jennifer Griggs.For more information on the podcast, please visit www.thedignitylab.com.For more information on podcast host Dr. Jennifer Griggs, please visit https://jennifergriggs.com/.For additional free resources, including the periodic table of dignity elements, please visit https://jennifergriggs.com/resources/.The Dignity Lab is an affiliate of Bookshop.org and will receive 10% of the purchase price when you click through and make a purchase. This supports our production and hosting costs. Bookshop.org doesn't earn money off bookstore sales, all profits go to independent bookstores. We encourage our listeners to purchase books through Bookshop.org for this reason.
The flipped classroom is a pedagogical approach to create active learning experiences in the nursing classroom. Dr. Blumenstock developed the DIET-RX acronym for a series of steps faculty can use when teaching with a flipped classroom approach. Learn more about DIET RX in this podcast and her article.
Ireland is prescribing a staggering 50% less hearing aids, per capita, than the UK. Why is this, and what can be done to help more people?Joining Seán to discuss is Brendan Lennon, Director of Advocacy for Chime…
The 154th episode of the Healthcare IT Today Podcast is sponsored by DrFirst, and this time we are talking about optimizing the medication journey from prescribing to adherence to improved outcomes with special guest host Colin Banas, MD, MHA, Chief Medical Officer at DrFirst! We kick this episode off by discussing what it takes now […]
WAAW! This week, to celebrate World AMR Awareness Week, Callum is Joined by Andrew, Fran, Jo and Simon from the Scottish Antimicrobial Prescribing Group. Listen in to hear all about SAPG and their important work, plus we discuss WAAW and what you can do to help tackle AMR.Show notes for this episode here, including links to the resources mentioned.Sign up to be an #antibioticguardian here.Send us a text Support the showQuestions, comments, suggestions to idiotspodcasting@gmail.com or on X/Threads @IDiots_podPrep notes for completed episodes can be found here (Not all episodes have prep notes).If you are enjoying the podcast please leave a review on your preferred podcast app!Feel like giving back? Donations of caffeine gratefully received!https://www.buymeacoffee.com/idiotspod
In this special live episode of Join the Docs, recorded amid the lively buzz of the Cheerful Ear Podcast Festival, our beloved medical duo—surgeon and pun enthusiast Jonathan Sackier, and GP-turned-stand-up-comedian Nigel Guest—step out from behind the mic and onto the stage to bring their comedic clinic to a live audience. It's not your typical episode; instead of their usual studio setup, Jonathan and Nigel dive into the quirks and curiosities of healthcare with real-time reactions, laughter, and applause from an audience eager to join in the fun.As they entertain a crowd brimming with podcast fans, The Docs revisit some of their most memorable moments from previous episodes, recounting tales that left listeners in stitches (metaphorically speaking). From the bizarre patient who thought a hard boiled egg belonged where the sun don't shine to the lady who was convinced she was a poached egg, these fan-favourite stories come to life in front of an audience who's hanging on every word.The festival atmosphere brings a new energy to the show as Jonathan and Nigel invite the audience to share their own medical misadventures, guess the most obscure diagnoses, and laugh along in real time. It's a fitting setting for The Docs who firmly believe that laughter is the best medicine—whether it's curing a rough day or simply lightening the load of medical life. So, grab a seat and get ready to join in on the laughter, camaraderie, and quick-witted exchanges that make Join the Docs a crowd favourite. This episode, recorded live, is bound to deliver a generous dose of humour with just the right prescription for fun—no copay required.—--DISCLAIMER: The views and opinions expressed on Join the Docs are those of Dr. Nigel Guest, Jonathan Sackier and other people on our show. Be aware that Join the Docs is not intended to be medical advice, it is for information and entertainment purposes only - please, always take any health concerns to your doctor or other healthcare provider. We respect the privacy of patients and never identify individuals unless they have consented. We may change details, dates, place names and so on to protect privacy. Listening to Join the Docs, interacting on our social media, emailing or writing to us does not establish a doctor patient relationship.To Contact Us: For a deeper dive on this episode's issue, merchandise and exclusive content, head to www.jointhedocs.comFollow us on youtube.com/JoinTheDocs Follow us on instgram.com/JoinTheDocsFollow us on tiktok.com/JoinTheDocsFollow us on: facebok.com/JoinTheDocsFollow us on: x.com/JoinTheDocs
It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: iPhone control for Omnipod 5 rolls out, Libre is approved for use in CT scans and MRIs, Dexcom files for 15 day wear, Luna nighttime pump goes to trial, iLet cell trials move forward and more! Find out more about Moms' Night Out Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Insulet Corporation announces the full market release of the Omnipod 5 App for iPhone® in the U.S. App allows users to fully control their Omnipod 5 Automated Insulin Delivery System (Omnipod 5) from their compatible iPhone1. For example, users can bolus for a meal, change a Pod, and adjust settings. Importantly, this also means that Omnipod 5 users who have a compatible iPhone no longer need to carry a separate Controller to help manage their insulin delivery requirements. Insulet says that the App for iPhone has been the number one feature requested by Omnipod 5 users. The Omnipod 5 App for iPhone is currently compatible with the Dexcom G6 Continuous Glucose Monitoring (CGM) System and is expected to be compatible with the Dexcom G7 CGM in the U.S. in 2025. The Omnipod 5 App for Android phones is also available to U.S. customers. https://www.businesswire.com/news/home/20241029838744/en/Omnipod%C2%AE-5-App-for-iPhone%C2%AE-Now-Fully-Available-in-the-United-States XX Th FDA says it's okay to keep on your FreeStyle Libre 2 and 3 for procedures like X-rays, CT scans and MRIs. Abbott said it makes its systems the first and only patient-applied CGM sensors approved for these screenings. Imaging procedures often come as part of diabetes care, Abbott said, especially as diabetes can cause a number of medical complications. The company rigorously tested its Libre 2 and 3 sensors to ensure they remain effective after radiologic procedures. This FDA clearance comes with no changes made to the sensor. https://www.drugdeliverybusiness.com/fda-approves-abbott-cgms-medical-imaging/ XX Tidepool announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors (CGMs). The companies aim to deliver cloud-to-cloud integration for an automatic stream of data from patients using Abbott's CGMs in the U.S. Data streams to Tidepool+, a diabetes data visualization and population health platform. Tidepool+ provides intuitive tracking and visualization of diabetes data to make the data informative and actionable for clinicians, people with diabetes and caregivers. https://www.drugdeliverybusiness.com/tidepool-abbott-data-integration-freestyle-libre/ XX Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) FreeStyle Libre 3 Plus. The companies announced their plan to combine the FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with iLet last month. According to Beta Bionics, this makes iLet the first available automated insulin delivery (AID) system to integrate with Libre 3 Plus in the U.S. iLet users can now update their app and software to gain a choice of integrated CGMs. They can choose between Libre 3 Plus and Dexcom CGMs. Abbott, meanwhile, continues to push forward on the automated insulin delivery integration front. The company recently paired its FreeStyle Libre 2 Plus with Insulet's Omnipod 5 in Europe. It also announced compatibility with the Tandem Diabetes Care t:slim X2 system in January. Notably, the company also struck a deal with Medtronic in August. They aim to develop CGMs specifically for the medtech giant's own insulin delivery systems. https://www.drugdeliverybusiness.com/beta-bionics-launches-ilet-abbott-libre/ XX Dexcom is asking the FDA to approve the G7 CGM for 15 days. Right now the G7 has a 10 day wear time. Dexcom also launched the G7 CGM in Australia and rolled out Dexcom ONE+ in France. Some front-office news.. EVP and CCO Teri Lawver plans to retire at the end of the year. https://www.drugdeliverybusiness.com/dexcom-submits-15-day-cgm-fda-q3-2024/ XX Stelo by Dexcom is one of TIME's Best Inventions of 2024! As the first glucose biosensor available in the U.S. without a prescription, Stelo has unlocked our industry-leading technology for millions of people across the U.S. looking to improve their health through personalized insights. We're honored to be recognized among other unique innovations in the Home Health category that support people's health. https://time.com/7094684/dexcom-stelo/ XX Luna Diabetes is moving forward with a pivotal trial evaluating its automated closed-loop insulin technology, the Luna System. This is designed to address nighttime glucose control for insulin pen users. It's meant for use only during sleep - Luna system was developed as a wearable insulin pump and alternative to insulin pen to automate the insulin delivery process. The device works with continuous glucose monitors (CGM) to calculate and deliver rapid-acting insulin doses during sleep. Luna Diabetes expects the study to be completed early next year, with plans to commercially launch the device “soon after”. https://finance.yahoo.com/news/luna-diabetes-trials-automated-wearable-115211566.html?guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAJIrWwjdye-ehrLNDt-LIGb5qTXaKDTIa8NWwiT7fKwFFgjDMN2nnINis6YfFePWP2ZA2DVYWXEIZQqRlQ4aKLFrYWgvw1jdI-t1n9kO6NIzdBCMXQNNCVl_S-75lDNip2SysHDJQmyqSc4wLjfDya3v9wwTWU-KgE_OqrPCTnlu XX Researchers are urging caution when prescribing off-label glucose-lowering drugs to individuals with type 1 diabetes (T1D) while acknowledging that doctors keep prescribing them because they seem to work so well. Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown significant benefits for cardiovascular and renal health in other populations, particularly in patients with type 2 diabetes. SGLT2 inhibitors carry a significant risk of euglycemic diabetic ketoacidosis, a dangerous condition most common in T1D individuals where toxic levels of blood acidification can occur. Due to this risk, SGLT2 inhibitors were removed for T1D use in Europe, and the U.S. Food and Drug Administration (FDA) has not approved them for T1D. For GLP-1RAs, there are concerns about substantial weight loss potentially leading to ketoacidosis or worsening hypoglycemia. While these medications can be beneficial in managing weight, the extent of that weight loss can create new problems in people with T1D as their insulin needs may quickly change as a result. Prescribing in People With Type 1 Diabetes," published in JAMA, the authors stress the critical need for more research to confidently allow the off-label usage of potentially dangerous secondary treatments. The data suggests clinicians are turning to these treatments to manage cardiovascular and renal complications in T1D patients, even though the drugs are not explicitly approved for this condition. Conversely, those newly prescribed GLP-1RAs had higher rates of obesity (69.4% vs. 45.7%). This data indicates that clinicians are prescribing GLP-1RAs to help manage obesity in T1D patients, as weight management is a critical component of diabetes care. The percentage of the T1D population prescribed GLP-1RAs increased significantly, from 0.3% in 2010 to 6.6% by 2023. The percentage prescribed SGLT2 inhibitors rose from 0.1% in 2013 to 2.4% by 2023. Overall, the percentage of T1D patients prescribed either of these medications increased from 0.7% to 8.3% during this period. Results of the study suggest that despite regulatory concerns, off-label use of GLP-1RAs and SGLT2 inhibitors in T1D continues to grow primarily due to their cardiorenal and weight management benefits. "Prospective studies on the efficacy and safety of GLP-1RAs or SGLT2 inhibitors in the T1D population are needed," the Research Letter concludes, "Before such evidence becomes available, caution should be exercised when prescribing these treatments to individuals with T1D." https://medicalxpress.com/news/2024-10-glucose-lowering-drugs-diabetes-patients.html XX More good islet transplant news.. from Eledon Pharmaceuticals and University of Chicago. These are potentially the first human cases of insulin independence achieved using a transplant of insulin-producing islet cells in combination with its experimental immunosuppressant drug. The first two subjects achieved insulin independence and normal hemoglobin A1C (HbA1c) levels, a measure of average blood glucose, post-transplant. The third subject, who recently received an islet transplant, decreased insulin use by more than 60% three days following the procedure and continues on an insulin independence trajectory. Some of the funding for this study comes from Breakthrough T1D. https://www.globenewswire.com/news-release/2024/10/29/2970713/0/en/Eledon-Pharmaceuticals-Announces-Positive-Initial-Data-from-Subjects-with-Type-1-Diabetes-Treated-with-Tegoprubart-as-Part-of-an-Immunosuppression-Regimen-Following-Islet-Transplan.html XX Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits compared to other diabetes drugs. published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, the study suggests that T2D patients taking semaglutide had a significantly lower risk of developing Alzheimer's. This effect was observed consistently across various subgroups, including differences in obesity status, gender, and age. Semaglutide, which acts on glucagon-like peptide receptors (GLP-1R) to curb hunger and regulate blood sugar in T2D, is also the active component in the diabetes and weight-loss drugs Wegovy and Ozempic. About 120,000 Americans die from Alzheimer's disease each year, with the disease listed as the seventh-leading cause of death nationally, according to the CDC. https://scitechdaily.com/alzheimers-breakthrough-popular-diabetes-drug-ozempic-linked-to-much-lower-risk/ XX XX Edgepark commercial XX Apple's non invasive blood glucose monitoring rumors are back. But this sounds like just software.. no watch or hardware. According to the report, Apple doesn't currently have plans to release the app, but may integrate the technology into its future health products. The app could reportedly show consumers how certain foods impact their blood sugar levels, based on measurements taken by existing blood sugar monitoring devices. One report says apple is exploring uses for blood sugar data and what tools they could create for consumers as a result. Latterly, he reports testing on the app has been paused, but says the tests could pave the way for better food tracking on Apple's own health software or better third-party glucose tracking integration. https://www.techradar.com/health-fitness/apple-is-testing-a-new-blood-sugar-product-but-its-not-the-apple-watch-update-weve-been-waiting-for XX And finally, it's diabetes awareness month. Please follow on social – I'll be doing a few things but mostly I think this month is great to educate the general public.. every month is diabetes month for this community. XX Join us again soon!
Increasing fruit and vegetable consumption sounds so trivial, but I honestly believe that concerted efforts to increase this key measure of our diet quality would culminate in success. And by success I mean successfully improving people's health, but also increasing the wealth of our communities and alleviating our nation's food supply insecurity.To explore this concept further with me is Jonathan Pauling, CEO of Alexandra Rose, one of my favourite charities and one that Doctor's Kitchen supports.10 years ago Jonathan helped develop its new mission - to improve access to healthy and affordable food for all. They built the ‘Rose Vouchers' for Fruit & Veg Project to pioneer the use of financial incentives to help families on low incomes avoid food insecurity, nutrition insecurity and food related ill-health. From small pilots in London supporting 45 families, this work has now spread around the UK supporting 3,500 families every week.The scheme works by giving families literal cash in the form of rose vouchers that can be used at local food markets in exchange for fresh produce. It's increased fruit and vegetable consumption by a staggering amount as we'll get into during the podcast, and I was genuinely shocked at some of the impressive numbers that Jonathan shared with me.Today we explore the economic and health incentives for why this scheme should be adopted across every local authority and NHS commissioners to not only help the millions of people living in financial hardship in the UK, but also to alleviate the burden on our health system.
In a Nutshell: The Plant-Based Health Professionals UK Podcast
This week we are discussing chronic fatigue syndrome (CFS) with Dr Tila Kansagra. Dr Kansagra is a UK based GP of British South Asian heritage who's Board certified in lifestyle medicine and has a certificate in plant based nutrition as well as lifestyle medicine for cancer prevention and survivorship. She practices as a GP specialist in ME/ CFS and fibromyalgia. She is a passionate advocate for plant-based nutrition and other lifestyle factors in the prevention and treatment of chronic disease. She enjoys sharing her love of plant -based nutrition through recipes on her website and now a YouTube channel with her mum. Tila goes by the name of Plant Promoting Doctor.To contact Tila:Instagram: @plant_promoting_doctorWebsite: www.plantpromotingdoctor.comYouTube: https://www.youtube.com/channel/UCknRthoJOWoTxuyOf2nzh4A
Send us a textNearly all insured Americans have prescription medication benefits.So why are so many Americans struggling to afford those prescriptions?Shouldn't these benefits cover the cost? In this episode of CareTalk, David Williams speaks with Kyle Kiser, CEO of Arrive Health, to explore the factors driving the disconnect between consumer needs and prescription pricing, and how point-of-prescribing technology can serve as a patient-centered solution. This episode is brought to you by BetterHelp. Give online therapy a try at https://betterhelp.com/caretalk and get on your way to being your best self.As a BetterHelp affiliate, we may receive compensation from BetterHelp if you purchase products or services through the links provided.TOPICS(0:17) Sponsorship(2:01) Why Is Medication Access an Issue?(4:23) What Happened to Affordable Medicine?(5:14) The State of Prior Authorization(7:08) Why Hasn't Electronic Prescribing Solved Consumer Constraints?(8:58) What Is Patient-Centered, Provider-Friendly Tech?(13:18) The Issues with Preferred Pharmacies(15:34) How Have Pharma Support Programs Evolved?(18:12) The Role of Biosimilars in Reducing Prices(19:38) What Should a Patient Know When Dealing with Prescription Costs?
Millions of Canadians don't have a family doctor. Walk-ins and ERs are packed. Access to primary care can be almost impossible for many of us. In an attempt to ease some of that burden on the system, a handful of provinces have allowed pharmacists to diagnose and prescribe medications for so-called "minor ailments". And in some provinces the list of those ailments is growing.For those without access to care, it can be a huge help. But it also raises questions about everything from training and privacy to conflicts of interest and misdiagnoses. So, is the potential cost worth the benefit of easing some of the strain on the system? And if not, what else are we supposed to do?GUEST: Natalie Mehra, Executive Director of the Ontario Health Coalition We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:Through email at hello@thebigstorypodcast.ca Or by calling 416-935-5935 and leaving us a voicemailOr @thebigstoryfpn on Twitter
In this interview with Dr. Bret Scher, Dr. Mark Horowitz, a leading clinician and researcher in anti-depressant withdrawal and de-prescribing, delves into the complex world of de-prescribing anti-depressants. Dr. Horowitz shares his personal journey with antidepressant withdrawal, which led him to dedicate his career to understanding safe tapering practices. He discusses the challenges that patients face when coming off medications, the withdrawal effects often mistaken for relapses, and how the current psychiatric guidelines may fall short in helping people safely taper. Dr. Horowitz emphasizes the importance of individualized tapering plans and the need for slower, more gradual reductions in medication, challenging the traditional approach of quick tapers over a few weeks. *Key Topics Covered* • The difference between withdrawal symptoms and relapse • The effects of long-term antidepressant use • Dr. Horowitz's personal experience with tapering off Lexapro • The role of clinicians and peer support in the de-prescribing process *Experts Featured* Dr. Mark Horowitz X: @markhoro https://markhorowitz.org/ Resources: Safe tapering resources: https://www.outro.com/ _The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs (The Maudsley Prescribing Guidelines Series)_ https://www.amazon.com/Maudsley-Guidelines-prescribing-Prescribing/dp/111982298X Metabolic Mind's Families & Peers page: https://www.metabolicmind.org/families-and-peers Clinician Directory: https://www.diagnosisdiet.com/directory Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/ About us: Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them. Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications. #MetabolicMind #MetabolicNeuroscience #KetogenicMetabolicTherapy #NutritionalKetosis#AlternativeTreatment#PsychiatricMedication#KetogenicTherapy #Tapering#Deprescribing
We sit down with Patrick Hunt, a physician executive, to explore one of the most pressing challenges in U.S. health care—the growing physician shortage. With projections indicating a shortfall of up to 86,000 doctors by 2036, Patrick shares his insights on how workforce management technology can help mitigate this crisis. We discuss how these innovations optimize staffing, improve physician well-being, and maintain quality care, especially in underserved communities. Patrick Hunt is a physician executive. He discusses the KevinMD article, "Prescribing data and efficiency: Harnessing technology to alleviate the physician shortage in the U.S." Our presenting sponsor is DAX Copilot by Microsoft. Do you spend more time on administrative tasks like clinical documentation than you do with patients? You're not alone. Clinicians report spending up to two hours on administrative tasks for each hour of patient care. Microsoft is committed to helping clinicians restore the balance with DAX Copilot, an AI-powered, voice-enabled solution that automates clinical documentation and workflows. 70 percent of physicians who use DAX Copilot say it improves their work-life balance while reducing feelings of burnout and fatigue. Patients love it too! 93 percent of patients say their physician is more personable and conversational, and 75 percent of physicians say it improves patient experiences. Help restore your work-life balance with DAX Copilot, your AI assistant for automated clinical documentation and workflows. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended GET CME FOR THIS EPISODE → https://www.kevinmd.com/cme I'm partnering with Learner+ to offer clinicians access to an AI-powered reflective portfolio that rewards CME/CE credits from meaningful reflections. Find out more: https://www.kevinmd.com/learnerplus
Join Bryce Kaminsky on the Property Profits Podcast as he chats with Mohamed Fakih, a physician turned real estate investor from Michigan. Discover how Mohamed balances his career in medicine with his passion for real estate, aiming to build generational wealth and live life on his own terms. Learn about the challenges and strategies of managing properties, the importance of knowing your market, and the potential benefits of investing in real estate. Whether you're new to real estate or looking to expand your portfolio, Mohamed's journey and insights offer valuable lessons in pursuing financial independence alongside a demanding career. Tune in for an engaging conversation on making smart investment choices that pave the way to achieving your dreams. ================================== Want to grow your real estate investing business and portfolio? You're in the right place. Welcome to the Property Profits Real Estate Podcast
What should we expect from the state-level advance of prescribing psychologists, non-physicians who are able to prescribe certain medications? Jeff Singer says their potential for helping patients is strong. Hosted on Acast. See acast.com/privacy for more information.